Generic Drugs Market Forecast 2018-2028

Generic Drugs Market Forecast 2018-2028
Visiongain has launched a new pharma report Generic Drugs Market Forecast 2018-2028: Growth in Leading Regional and National Markets – North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico The generic drugs market has ...

Global Biosimilar Monoclonal Antibodies Forecast 2018-2028

Global Biosimilar Monoclonal Antibodies Forecast 2018-2028
LONDON, UK. February 2018: Visiongain’ has launched a new pharma report Global Biosimilar Monoclonal Antibodies Forecast 2018-2028: Biosimilar Versions of Infliximab, Rituximab, Trastuzumab, Adalimumab, Bevacizumab and Abciximab Biosimilar monoclonal antibodies (mAbs) form an emerging sector in pharmaceuticals. As patents for some of the industry’s top-selling biological drugs (biologics) expire, companies have chosen to invest in ...

Drug Delivery Technologies Market Forecast 2018-2028

Drug Delivery Technologies Market Forecast 2018-2028
LONDON, UK. 31st January 2018: Visiongain has launched a new pharma report Drug Delivery Technologies Market Forecast 2018-2028: Analysis of Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular and Nasal/Buccal Drug Delivery Technologies; Forecasts for Biologics, Vaccines and Major National Markets and Assessment of Leading Drug Delivery Companies By definition, drug delivery is the method or process of ...

Global Growth Hormone Drugs Market Forecast to 2027: Somatropin and Mecasermin Based Drugs, Innovator Generics and Biosimilars, Norditropin, Genotropin, Humatrope, Saizen, Nutropin, Omnitrope, Zomacton, R&D and Leading Companies

Global Growth Hormone Drugs Market Forecast to 2027: Somatropin and Mecasermin Based Drugs, Innovator Generics and Biosimilars, Norditropin, Genotropin, Humatrope, Saizen, Nutropin, Omnitrope, Zomacton, R&D and Leading Companies
LONDON, UK. 29th November 2017: Visiongain has launched a new Pharmaceutical Report Global Growth Hormone Drugs Market Forecast to 2027: Somatropin and Mecasermin Based Drugs, Innovator Generics and Biosimilars, Norditropin, Genotropin, Humatrope, Saizen, Nutropin, Omnitrope, Zomacton, R&D and Leading Companies. The report forecasts the overall growth hormone drugs market will multiply in revenues from 2017 ...

Biologics Market Trends and Forecasts to 2027: Evaluation of Therapeutic Segments Including Monoclonal Antibodies, Insulin, Fusion Proteins, Interferons and Gene Therapies; Prediction of Leading National Markets; Investigation of Top Products Including Humira, Remicade, Lantus and Enbrel; and Assessment of R&D Including Sirukumab and NurOwn

Biologics Market Trends and Forecasts to 2027: Evaluation of Therapeutic Segments Including Monoclonal Antibodies, Insulin, Fusion Proteins, Interferons and Gene Therapies; Prediction of Leading National Markets; Investigation of Top Products Including Humira, Remicade, Lantus and Enbrel; and Assessment of R&D Including Sirukumab and NurOwn
LONDON, UK. 28th November 2017: Visiongain has launched a new pharma report Biologics Market Trends and Forecasts to 2027: Evaluation of Therapeutic Segments Including Monoclonal Antibodies, Insulin, Fusion Proteins, Interferons and Gene Therapies; Prediction of Leading National Markets (US, Japan, EU5 and BRIC); Investigation of Top Products Including Humira, Remicade, Lantus and Enbrel; and Assessment ...

Rheumatoid Arthritis Drugs Market 2017-2027: Trends, Progress and Revenue Forecasting: Evaluation of Classes and Products Including Humira, Enbrel, Remicade, Rituxan, Actemra and Biosimilars; Assessment of Leading Companies Including AbbVie, Roche, J&J, Amgen, Pfizer and Merck & Co.; Prediction of Leading National Markets; and Investigation of Late-Stage R&D Including IL-6, JAK, BTK and GM-CSF Inhibitors

Rheumatoid Arthritis Drugs Market 2017-2027:  Trends, Progress and Revenue Forecasting: Evaluation of Classes and Products Including Humira, Enbrel, Remicade, Rituxan, Actemra and Biosimilars; Assessment of Leading Companies Including AbbVie, Roche, J&J, Amgen, Pfizer and Merck & Co.; Prediction of Leading National Markets; and Investigation of Late-Stage R&D Including IL-6, JAK, BTK and GM-CSF Inhibitors
LONDON, UK. 2nd November 2017: Visiongain has launched a new pharma report Rheumatoid Arthritis (RA) Drugs Market 2017-2027: Trends, Progress and Revenue Forecasting: Evaluation of Classes (Biologic DMARDs, Synthetic DMARDs and Other Agents) and Products Including Humira, Enbrel, Remicade, Rituxan, Actemra and Biosimilars; Assessment of Leading Companies Including AbbVie, Roche, J&J, Amgen, Pfizer and Merck ...

Latin American Pharmaceutical Market Outlook 2018-2028: Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs

Latin American Pharmaceutical Market Outlook 2018-2028: Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs
LONDON, UK. October 2017: Visiongain has launched a new pharma report Latin American Pharmaceutical Market Outlook 2018-2028: Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs. The Latin American pharmaceutical market accounts for 8% of the global pharmaceutical industry, and is one of its fastest growing markets. Macroeconomic conditions ...

Global Asthma & COPD Therapies Market 2017-2027: Bronchodilator Monotherapy, Anticholinergics, Short-acting Beta-Agonists, Long-acting Beta-Agonists, Long-acting Muscarinic Antagonists, Anti-Inflammatory Drugs, Corticosteroids, Anti-Leukotrienes, Monoclonal Antibodies, Combination Drugs

Global Asthma & COPD Therapies Market 2017-2027: Bronchodilator Monotherapy, Anticholinergics, Short-acting Beta-Agonists, Long-acting Beta-Agonists, Long-acting Muscarinic Antagonists, Anti-Inflammatory Drugs, Corticosteroids, Anti-Leukotrienes, Monoclonal Antibodies, Combination Drugs
LONDON, UK. September 2017: Visiongain has launched a new pharma report Global Asthma & COPD Therapies Market 2017-2027: Bronchodilator Monotherapy, Anticholinergics, Short-acting Beta-Agonists (SABAs), Long-acting Beta-Agonists (LABAs), Long-acting Muscarinic Antagonists (LAMAs), Anti-Inflammatory Drugs, Corticosteroids, Anti-Leukotrienes, Monoclonal Antibodies, Combination Drugs The asthma & COPD market is maturing with generic competition looming for Advair, Symbicort, Spiriva and ...

Pharma Leader Series: 25 Top Biosimilar Drug Manufacturers, 2017-2027, and Other Rising Companies – a Market Report Assessing Developers and Producers of Competitor Biologics

Pharma Leader Series: 25 Top Biosimilar Drug Manufacturers, 2017-2027, and Other Rising Companies – a Market Report Assessing Developers and Producers of Competitor Biologics
LONDON, UK. 31st August 2017: Visiongain has launched a new pharma report Pharma Leader Series: 25 Top Biosimilar Drug Manufacturers, 2017-2027, and Other Rising Companies – a Market Report Assessing Developers and Producers of Competitor Biologics The EU defines a biological medicinal product as “a protein or nucleic acid-based pharmaceutical substance used for therapeutic or ...